Clinical evaluation of parenteral polythiazide (P-2525) administration.
D001769:Blood; D001786:Blood Glucose; D002712:Chlorides; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D008107:Liver Diseases / Q000188:drug therapy*; D009941:Organomercury Compounds / Q000008:administration & dosage*; D011139:Polythiazide / Q000008:administration & dosage*; D011188:Potassium; D012964:Sodium; D013223:Statistics as Topic; D014508:Urea; D014527:Uric Acid
D001786:Blood Glucose; D002712:Chlorides; D009941:Organomercury Compounds; D014527:Uric Acid; D011139:Polythiazide; D014508:Urea; D012964:Sodium; D011188:Potassium